ENDRA Life Sciences Inc.
Every calculator, already run for NDRA
Open the full toolkit →You have the numbers on NDRA. Get the argument.
A written report on which of these readings actually decide the outcome for ENDRA Life Sciences Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
1 analysts covering NDRAOwnership & short interest
Insider Trading Activity for NDRA
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
NDRA — frequently asked
Is NDRA a buy right now?
Wall Street's consensus rating on ENDRA Life Sciences Inc. is none across 1 analysts, with a mean price target of $25.00 (+355% vs. the current $5.50). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Compare ENDRA Life Sciences Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For ENDRA Life Sciences Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full NDRA research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on ENDRA Life Sciences Inc., in minutes. 3 free reports included with every account — no credit card required.